Samuel Callisto, Ph.D.

Research Scientist II

Samuel joined MetrumRG in 2019 after earning his PhD in Experimental and Clinical Pharmacology with an emphasis in Pharmacometrics from the University of Minnesota College of Pharmacy. His thesis work focused on modeling cognitive side effects of the anti-epileptic drug topiramate using a combination of pharmacokinetic-pharmacodynamic models and unsupervised machine learning algorithms. While in graduate school he also researched the impact of pharmacogenomics on the pharmacokinetics and pharmacodynamics of multiple drug classes.

Recent publications by this scientist

An Empirical Approach to Identifying Electrophysiological Correlates of Topiramate-Related Working Memory Impairment Using Pharmacokinetic-Pharmacodynamic Modeling

March 29, 2022

Samuel P. Callisto, Christopher M. Barkley, Mark Fiecas, Richard Brundage, Angela K. Birnbaum, Susan E. Marino.┬áPoster presented at 2022 WCOP. March 29 – April 1 2022. Poster 35.

View More